Chronic Kidney Disease Antidepressant Sertraline Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT00946998
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT00946998
-
- Main results
- Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial
- Other papers using this trial's data
- Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT00946998. Randomized; quadruple masking; primary purpose treatment. Start 2010-02-08 (actual); primary completion 2016-11-23 (actual). Results posted on 2018-01-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Chronic Kidney Disease Antidepressant Sertraline Trial
- Acronym
- CAST
- Condition
- Chronic Kidney Disease
- Condition
- Depression
- Intervention (Drug)
- Sertraline
- Intervention (Drug)
- placebo
- Lead sponsor
- VA Office of Research and Development
- Collaborator
- University of Texas Southwestern Medical Center
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct00946998- Content hash
d70a1b1e5faadce18d17aa10c060cff49e275dd09a3f018530b30bd212b045bf